Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration
Biomolecules and Biomedicine · 29.02.2024 · 24 (4) · 912-922
DOI: 10.17305/bb.2024.10304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 29.02.2024. Verfasst von Xuefei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Sirtuin 1, Lipid Metabolism, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clear cell renal cell carcinoma (ccRCC) is a malignancy with a dismal prognosis, caused by the buildup of fat and glycogen. Sirtuin 1 (Sirt1) is a deacetylase that regulates lipid metabolism. In this study, we collected tumor and paracancer tissues from 386 ccRCC patients and followed their prognosis over an extended time period. The expression of Sirt1 in these tissues was assessed using immunohistochemistry, and LinkedOmics database analysis identified differentially expressed genes associated with Sirt1. The survival curve was generated using the Kaplan-Meier method, and immune infiltration was analyzed using the Tumor Immune Estimation Resource (TIMER) web tool. Our findings revealed that Sirt1 was expressed in tumor tissues, but not in normal tissues, and its high expression was associated with a worse prognosis. Furthermore, we observed a positive correlation between high Sirt1 expression and perirenal fat invasion and necrosis, leading to poorer survival outcomes. We established a nomogram to predict prognosis, and a correlation was observed with immune infiltration. In conclusion, our results suggest that high Sirt1 expression is associated with lipid metabolism disorder and immune infiltration, ultimately contributing to a dismal prognosis in ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; Department of Pathology, Sun Yat-sen University Cancer Center…
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; Department of Comprehensive Traditional Chinese Medicine, Sun…
- Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zitieren
APA
Wang, X., Deng, F., Liu, J., Wang, J., Chen, Q., & Lu, J. (2024). Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration. Biomolecules and Biomedicine, 24(4), 912-922. https://doi.org/10.17305/bb.2024.10304
Vancouver
Wang X, Deng F, Liu J, Wang J, Chen Q, Lu J. Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration. Biomolecules and Biomedicine. 2024;24(4):912-922. doi:10.17305/bb.2024.10304
BibTeX
@article{Wang2024,
author = {Wang, Xuefei and Deng, Fangqi and Liu, Jiexi and Wang, Jiayu and Chen, Qing and Lu, Jiabin},
title = {Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration},
journal = {Biomolecules and Biomedicine},
year = {2024},
volume = {24},
number = {4},
pages = {912--922},
doi = {10.17305/bb.2024.10304}
}
EUVIMED